🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Neurogenetic diseases (NGD) represent rare and hereditary forms of neurolog...
Status
Recruiting
Location
Chu de Bordeaux
Start Date
2024-07-18
Trial ID
NCT06048523
Treatments Being Tested
The purpose of this research study is to see if investigators can predict h...
Status
Recruiting
Location
Wake Forest Baptist Comprehensive Cancer Center
Start Date
2022-09-02
Trial ID
NCT05212272
The primary aim of this nationwide, explorative, cross-sectional study in G...
Status
Unknown
Location
Friedrich-Baur-Institute, Dep. of Neurology Klinikum der Universitaet Muenchen
Start Date
2022-03-31
Trial ID
NCT05272969
Treatments Being Tested
This phase II trial studies how well de-escalating the drugs dabrafenib and...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-11-07
Trial ID
NCT07110246
This study employs novel methods to identify key determinants and consequen...
Status
Completed
Location
Washington University School of Medicine
Start Date
2022-03-23
Trial ID
NCT05430490
Treatments Being Tested
In this study the investigators would like to investigate the degree of dam...
Status
Recruiting
Location
University of Exeter
Start Date
2021-09-01
Trial ID
NCT05121012
Treatments Being Tested
This phase II trial studies how well lower dose radiotherapy after chemothe...
Status
Recruiting
Location
USA Health Strada Patient Care Center
Start Date
2024-10-22
Trial ID
NCT06368817
Treatments Being Tested
Many elderly patients undergoing surgical procedures already have impaired ...
Status
Unknown
Location
Toronto General Hospital, University Health Network
Start Date
2014-03
Trial ID
NCT01903421
This project will define the prevalence of brain health (i.e., normal cogni...
Status
Recruiting
Location
University of Pittsburgh Department of Neurosurgery
Start Date
2019-11-18
Trial ID
NCT04708613
Progranulin (GRN or PGRN) mutations are among the most common genetic cause...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-01
Trial ID
NCT06711510